These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30027696)

  • 1. Clinical Utility and Cross-Reactivity of Insulin and C-Peptide Assays by the Lumipulse G1200 System.
    Oh J; Kim JH; Park HD
    Ann Lab Med; 2018 Nov; 38(6):530-537. PubMed ID: 30027696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of LUMIPULSE(®) G1200 With Kryptor and Modular E170 for the Measurement of Seven Tumor Markers.
    Marlet J; Bernard M
    J Clin Lab Anal; 2016 Jan; 30(1):5-12. PubMed ID: 25283278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated measurement of 25-OH Vitamin D on the LUMIPULSE
    Parra M; Foj L; Filella X
    Br J Biomed Sci; 2016 Jul; 73(3):104-109. PubMed ID: 27310165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Lumipulse® G1200 for the measurement of six tumor markers: Comparison with AIA® 2000.
    de Rancher MR; Oudart JB; Maquart FX; Monboisse JC; Ramont L
    Clin Biochem; 2016 Nov; 49(16-17):1302-1306. PubMed ID: 27521619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance evaluation of LUMIPULSE G1200 autoimmunoanalyzer for the detection of serum hepatitis B virus markers.
    Choi SJ; Park Y; Lee EY; Kim S; Kim HS
    J Clin Lab Anal; 2013 May; 27(3):204-6. PubMed ID: 23440745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verification of the harmonization of human epididymis protein 4 assays.
    Ferraro S; Borille S; Carnevale A; Frusciante E; Bassani N; Panteghini M
    Clin Chem Lab Med; 2016 Oct; 54(10):1635-43. PubMed ID: 27028735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance evaluation of serum PIVKA-II measurement using HISCL-5000 and a method comparison of HISCL-5000, LUMIPULSE G1200, and ARCHITECT i2000.
    Ryu MR; Kang ES; Park HD
    J Clin Lab Anal; 2019 Jul; 33(6):e22921. PubMed ID: 31131509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-reactivity of insulin analogues with three insulin assays.
    Dayaldasani A; Rodríguez Espinosa M; Ocón Sánchez P; Pérez Valero V
    Ann Clin Biochem; 2015 May; 52(Pt 3):312-8. PubMed ID: 25172526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performance of the ARCHITECT C-Peptide immunoassay.
    Schultess J; van Duren C; Martens M; Costa M; Llop T; Martí T; Eppinger M; Hausmann M; Krack W; Dhein J
    Clin Chem Lab Med; 2009; 47(7):834-41. PubMed ID: 19496736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated chemiluminescent assay for C-peptide.
    Hardy RW; Cohn M; Konrad RJ
    J Clin Lab Anal; 2000; 14(1):17-9. PubMed ID: 10645980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical Evaluation of Lumipulse Anti-Mullerian Hormone Assay.
    Fraissinet F; Gesland A; Guillerme J; Ziegler F; Brunel V
    Clin Lab; 2021 Jun; 67(6):. PubMed ID: 34107635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a new automated immunoassay for the quantification of anti-Müllerian hormone.
    Lotierzo M; Urbain V; Dupuy AM; Cristol JP
    Pract Lab Med; 2021 May; 25():e00220. PubMed ID: 34095410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytical evaluation of the novel Lumipulse G BRAHMS procalcitonin immunoassay.
    Ruzzenente O; Salvagno GL; Gelati M; Lippi G
    Pract Lab Med; 2016 Dec; 6():8-13. PubMed ID: 28856208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical evaluation and clinical application of insulin and C-peptide by a whole blood, lateral flow, point of care (POC) assay system.
    Jekarl DW; Choi H; Kim ES; Lee S; Park HI; Kim M; Kim Y
    Scand J Clin Lab Invest; 2019 Sep; 79(5):347-353. PubMed ID: 31210062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of an enzyme-linked immunosorbent assay for C-peptide analysis in Cameroon.
    Asanghanwa M; van Genderen F; Verhaeghen K; Van der Auwera B; Sobngwi E; Mbanya JC; van Schravendijk C
    Diabetes Res Clin Pract; 2012 Dec; 98(3):459-64. PubMed ID: 23089552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical evaluation of Lumipulse® BRAHMS PCT CLEIA assay and clinical performances in an unselected population as compared with central lab PCT assay.
    Dupuy AM; Né M; Bargnoux AS; Badiou S; Cristol JP
    Clin Biochem; 2017 Mar; 50(4-5):248-250. PubMed ID: 27838408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reference intervals for C-peptide and insulin derived from a general adult Danish population.
    Larsen PB; Linneberg A; Hansen T; Friis-Hansen L
    Clin Biochem; 2017 May; 50(7-8):408-413. PubMed ID: 27989491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance evaluation and cross-reactivity from insulin analogs with the ARCHITECT insulin assay.
    Moriyama M; Hayashi N; Ohyabu C; Mukai M; Kawano S; Kumagai S
    Clin Chem; 2006 Jul; 52(7):1423-6. PubMed ID: 16690737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Lumipulse G TP-N Chemiluminescent Immunoassay as a Syphilis Screening Test.
    Ortiz DA; Loeffelholz MJ
    J Clin Microbiol; 2017 Nov; 55(11):3236-3241. PubMed ID: 28878003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of a Fully Automated Platform and an Established ELISA for the Quantification of Neurofilament Light Chain in Patients With Cognitive Decline.
    Agnello L; Gambino CM; Del Ben F; Ciaccio AM; Scazzone C; Lo Sasso B; Ciaccio M
    J Appl Lab Med; 2024 Nov; 9(6):990-1003. PubMed ID: 39311040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.